John R. Bradley

25.3k total citations · 3 hit papers
151 papers, 8.0k citations indexed

About

John R. Bradley is a scholar working on Molecular Biology, Immunology and Nephrology. According to data from OpenAlex, John R. Bradley has authored 151 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 32 papers in Immunology and 25 papers in Nephrology. Recurrent topics in John R. Bradley's work include Immune Response and Inflammation (11 papers), Renal Transplantation Outcomes and Treatments (10 papers) and Dialysis and Renal Disease Management (10 papers). John R. Bradley is often cited by papers focused on Immune Response and Inflammation (11 papers), Renal Transplantation Outcomes and Treatments (10 papers) and Dialysis and Renal Disease Management (10 papers). John R. Bradley collaborates with scholars based in United Kingdom, United States and Belgium. John R. Bradley's co-authors include Jordan S. Pober, S Thiru, Rafia S. Al‐Lamki, J.P. Waters, Rafia S. Al‐Lamki, Min Wang, David R. Johnson, Elizabeth C. Ledgerwood, J. Andrew Bradley and Kenneth G. C. Smith and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

John R. Bradley

147 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TNF‐mediated inflammatory disease

2007 1.5k citations John R. Bradley profile →
Tumor necrosis factor receptor-associated factors (TRAFs)

2001 543 citations John R. Bradley, Jordan S. Pober profile →
Spontaneous, persistent, T cell–dependent IFN-γ release in patients who progress to Long Covid

2024 41 citations Benjamin A. Krishna, Eleanor Y. Lim et al. Science Advances profile →

Peers

Countries citing papers authored by John R. Bradley

Since Specialization

Citations

This map shows the geographic impact of John R. Bradley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Bradley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Bradley more than expected).

Fields of papers citing papers by John R. Bradley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Bradley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Bradley. The network helps show where John R. Bradley may publish in the future.

Co-authorship network of co-authors of John R. Bradley

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Bradley. A scholar is included among the top collaborators of John R. Bradley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Bradley. John R. Bradley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tumor Necrosis Factor Receptor-2 Signals Clear-Cell Renal Carcinoma Proliferation via Phosphorylated 4E Binding Protein-1 and Mitochondrial Gene Translation 2024 ·American Journal Of Pathology ·Rafia S. Al‐Lamki, Aviva M. Tolkovsky, (unknown), (unknown), Sarah F. Field, Jun Wang, Jordan S. Pober, John R. Bradley	1
2	Spontaneous, persistent, T cell–dependent IFN-γ release in patients who progress to Long Covid breakdown → 2024 ·Science Advances ·Benjamin A. Krishna, Eleanor Y. Lim, (unknown), Sarah Jackson, Lenette Mactavous, (unknown), Paul Lyons, Rainer Döffinger, John R. Bradley, Kenneth G. C. Smith, John Sinclair, Nicholas J. Matheson, Paul J. Lehner, Nyaradzai Sithole, Mark R. Wills	41
3	Dynamics of cognitive variability with age and its genetic underpinning in NIHR BioResource Genes and Cognition cohort participants 2024 ·Nature Medicine ·(unknown), Emma Harrison, (unknown), (unknown), Paul Elliott, Gerome Breen, Nathalie Kingston, John R. Bradley, Steven M. Hill, Brian D. M. Tom, Patrick F. Chinnery	5
4	Evidence of previous SARS-CoV-2 infection in seronegative patients with long COVID 2022 ·EBioMedicine ·Benjamin A. Krishna, Eleanor Y. Lim, (unknown), Paul Lyons, Rainer Döffinger, John R. Bradley, Kenneth G. C. Smith, John Sinclair, Nicholas J. Matheson, Paul J. Lehner, Mark R. Wills, Nyaradzai Sithole	24
5	Effect of kidney donation on bone mineral metabolism 2020 ·PLoS ONE ·Thomas F. Hiemstra, J. Carson Smith, Kenneth Lim, Dihua Xu, (unknown), J. Andrew Bradley, Kaido Paapstel, Inez Schoenmakers, John R. Bradley, Laurie A. Tomlinson, Carmel M. McEniery, Ian B. Wilkinson	4
6	“Reasonable adjustments” under the UK's Equality Act 2010: An enquiry into the care and treatment to patients with intellectual disabilities in acute hospital settings 2019 ·Journal of Applied Research in Intellectual Disabilities ·Marcus Redley, (unknown), (unknown), Anthony Holland, Angela Thompson, John R. Bradley, Gyles Glover, (unknown), (unknown), (unknown), (unknown), I. C. H. Clare	11
7	Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys 2017 ·Science Translational Medicine ·Gregory T. Tietjen, Sarah A. Hosgood, (unknown), Jiajia Cui, Deeksha Deep, Eric Song, Jan R. Kraehling, Alexandra S. Piotrowski-Daspit, Nancy C. Kirkiles-Smith, Rafia S. Al‐Lamki, S Thiru, J. Andrew Bradley, Kourosh Saeb‐Parsy, John R. Bradley, Michael L. Nicholson, W. Mark Saltzman, Jordan S. Pober	112
8	Tubular epithelial cells in renal clear cell carcinoma express high RIPK1/3 and show increased susceptibility to TNF receptor 1-induced necroptosis 2016 ·Cell Death and Disease ·Rafia S. Al‐Lamki, Wenyu Lü, Pacita Manalo, (unknown), Anne Y. Warren, Aviva M. Tolkovsky, Jordan S. Pober, John R. Bradley	36
9	Saudi Arabia's Invisible Hand in the Arab Spring 2011 ·Foreign Affairs ·John R. Bradley	2
10	Identification and Regulation of Reticulon 4B (Nogo-B) in Renal Tubular Epithelial Cells 2010 ·American Journal Of Pathology ·Ethan P. Marin, Gilbert Moeckel, Rafia S. Al‐Lamki, John R. Bradley, Qingshang Yan, Tong Wang, Paulette L. Wright, Jun Yu, William C. Sessa	20
11	A rare life-threatening complication of an indwelling hemodialysis catheter 2007 ·Kidney International ·Avnesh S. Thakor, Thomas F. Hiemstra, John R. Bradley	3
12	Caveolae Participate in Tumor Necrosis Factor Receptor 1 Signaling and Internalization in a Human Endothelial Cell Line 2005 ·American Journal Of Pathology ·Alessio D’Alessio, Rafia S. Al‐Lamki, John R. Bradley, Jordan S. Pober	89
13	Radionuclide method for evaluating the performance of hemodialysis in vivo 2005 ·Kidney International ·(unknown), Nicholas J. Bird, Christina Peters, John R. Bradley, A. Michael Peters	1
14	Physiological aspects of pig-to-primate renal xenotransplantation 2001 ·Kidney International ·Bob Soin, Kenneth G. C. Smith, Afzal Zaidi, Emanuele Cozzi, John R. Bradley, Daniel J. Ostlie, Andrew Lockhart, (unknown), Peter Friend	68
15	Roundtable - In Cobol's Defense. 2000 ·IEEE Software ·(unknown), (unknown), John R. Bradley, (unknown), (unknown), (unknown), (unknown)	11
16	Cellular and Subcellular Distribution of Polycystin-2, the Protein Product of the PKD2 Gene 2000 ·Journal of the American Society of Nephrology ·Lukas Foggensteiner, A. Paul Bevan, Ruth Thomas, Nicholas Coleman, Catherine A. Boulter, John R. Bradley, Oxana Ibraghimov‐Beskrovnaya, K. Klinger, Richard Sandford	133
17	Identification of Mutations in the Repeated Part of the Autosomal Dominant Polycystic Kidney Disease Type 1 Gene, PKD1, by Long-Range PCR 1999 ·The American Journal of Human Genetics ·Ruth Thomas, Robert S. McConnell, (unknown), (unknown), John R. Bradley, Richard Sandford	87
18	PHASE I STUDY OF AN ENGINEERED AGLYCOSYLATED HUMANIZED CD3 ANTIBODY IN RENAL TRANSPLANT REJECTION1 1999 ·Transplantation ·Peter J. Friend, G Hale, Lucienne Chatenoud, P Rebello, John R. Bradley, S Thiru, Jenny M. Phillips, Herman Waldmann	104
19	Endothelial cell activation in patients with systemic vasculitis 1994 ·QJM ·John R. Bradley, C M Lockwood, S Thiru	32
20	Points from Letters: Hazards of Argyll Trocar Catheter 1975 ·BMJ ·John R. Bradley	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact